EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Seizure clusters, treatment patterns, and healthcare resource utilization in patients with epilepsy: A Wisconsin-based claims analysis

George L Morris, Pam Eads, Milena Tryfon, Derek Ems

Epilepsy & Behavior · 2024-08 · 157 · 109867

DOI: 10.1016/j.yebeh.2024.109867 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsy & Behavior, 2024-08. Verfasst von George L Morris und 3 weiteren Autor:innen. Beteiligte Einrichtung: Ascension Wisconsin, St. Mary's Hospital, 2301 N Lake Drive, Milwaukee, WI 53211 USA. Electronic address: george.morris@ascension.org. Hauptthemen laut MEDLINE: Epilepsy, Anticonvulsants, Seizures, Patient Acceptance of Health Care. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UCB, UCB Pharma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Seizure clusters are underresearched and associated with adverse outcomes in patients with epilepsy. This study was a noninterventional, retrospective claims-based analysis using the Wisconsin Health Information Organization (WHIO) All-Payer Claims Database to characterize the epilepsy population in Wisconsin, with a focus on prevalence, treatment patterns, and healthcare resource utilization (HCRU) in patients with seizure clusters prior to the introduction of nasal spray rescue medications. This timeframe allows characterization of a historical baseline for future comparisons with newer treatments. METHODS: Four cohorts were defined: (1) all-epilepsy (all patients with epilepsy); and subcohorts of: (2) patients receiving a monotherapy antiseizure medication (ASM); (3) patients receiving ASM polytherapy; and (4) patients treated for seizure clusters (ie, those taking rescue medications and ≥ 1 ASM). Primary outcomes were HCRU over a 12-month follow-up period, which were descriptively analyzed. RESULTS: Between 2017 and 2019, 16,384 patients were included in the all-epilepsy cohort; 11,688 (71.3 %) were on monotherapy, 3,849 (23.5 %) were on polytherapy, and 526 (3.2 %) were treated for seizure clusters. Twelve-month retentions to the ASM treatments were 46.7 % (7,895/16,904) in the all-epilepsy cohort, and 40.0 % (4,679/11,688) and 40.1 % (1,544/3,849) in the monotherapy and polytherapy subcohorts, respectively. Rescue medication prescriptions were obtained 1,029 times by the 526 patients in the treated seizure cluster subcohort, with infrequent refill rates (mean 1.6-1.9 times/year). A higher proportion of patients in the treated seizure cluster subcohort had epilepsy-related outpatient visits (89.7 %), other visits (71.3 %), and hospitalizations (25.3 %) than patients in the monotherapy (72.2 %, 50.2 %, 19.3 %, respectively) and polytherapy (83.3 %, 63.3 %, 22.8 %, respectively) subcohorts. Mean (standard deviation) all-cause ($114,717 [$231,667]) and epilepsy-related ($76,134 [$204,930]) costs over 12 months were higher in the treated seizure cluster subcohort than the monotherapy ($89,324 [$220,181] and $30,745 [$145,977], respectively) and polytherapy ($101,506 [$152,931] and $49,383 [$96,285], respectively) subcohorts. CONCLUSIONS: Patients treated for seizure clusters incurred higher all-cause and epilepsy-related costs and epilepsy-related HCRU than other subcohorts and had infrequent rescue medication refills. The findings of this analysis highlight the need for appropriate treatment for those patients with epilepsy experiencing seizure clusters. The effect of newer rescue medications to alter these findings will be explored in a follow-up study. Regardless, specialist providers with expertise in treating refractory epilepsy and seizure cluster patients may help to reduce the burden of seizure clusters.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilepsyAnticonvulsantsSeizuresPatient Acceptance of Health CareHumansMaleFemaleAdultMiddle AgedWisconsinRetrospective StudiesYoung AdultAdolescentAgedChildChild, PreschoolInfantInsurance Claim ReviewCohort Studies

Stichwörter der Autor:innen

Acute repetitive seizuresEpilepsyHealthcare resource utilizationReal-world dataSeizure clusters

Substanzen

Anticonvulsants

Autor:innen und Institutionen

  • Ascension Wisconsin, St. Mary's Hospital, 2301 N Lake Drive, Milwaukee, WI 53211 USA. Electronic address: george.morris@ascension.org.
  • UCB Pharma, 1950 Lake Park Dr, Smyrna, GA, USA. Electronic address: pam.eads@ucb.com.
  • UCB Pharma, Leona Kruczkowskiego 8 00-380, Warszawa, Poland. Electronic address: milena.tryfon@ucb.com.
  • UCB Pharma, 1950 Lake Park Dr, Smyrna, GA, USA. Electronic address: derek.ems@ucb.com.

Förderung

  • UCB
  • UCB Pharma

Zitieren

APA

Morris, G. L., Eads, P., Tryfon, M., & Ems, D. (2024). Seizure clusters, treatment patterns, and healthcare resource utilization in patients with epilepsy: A Wisconsin-based claims analysis. Epilepsy & Behavior, 157, 109867. https://doi.org/10.1016/j.yebeh.2024.109867

Vancouver

Morris GL, Eads P, Tryfon M, Ems D. Seizure clusters, treatment patterns, and healthcare resource utilization in patients with epilepsy: A Wisconsin-based claims analysis. Epilepsy & Behavior. 2024;157:109867. doi:10.1016/j.yebeh.2024.109867

BibTeX
@article{Morris2024,
  author = {Morris, George L and Eads, Pam and Tryfon, Milena and Ems, Derek},
  title = {Seizure clusters, treatment patterns, and healthcare resource utilization in patients with epilepsy: A Wisconsin-based claims analysis},
  journal = {Epilepsy & Behavior},
  year = {2024},
  volume = {157},
  pages = {109867},
  doi = {10.1016/j.yebeh.2024.109867}
}
Kostenlos starten →